TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15360 · Dec 23

#python#docker#fastapi#kbqa#kgqa#llms#neo4j#rag#vue Yuxi-Know (语析) is a free, open-source platform built with LangGraph, Vue.js, FastAPI, and LightRAG to create smart agents using RAG knowledge bases and knowledge graphs. The latest v0.4.0-beta (Dec 2025) adds file uploads, multimodal image support, mind maps from files, evaluation tools, dark mode, and better graph visuals. It helps you quickly build and deploy custom AI agents for Q&A, analysis, and searches without starting from scratch, saving time and effort on development. https://github.com/xerrors/Yuxi-Know

Results

1 similar post found

Search: #bitdca

当前筛选 #bitdca清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 02/26/2025, 01:00 PM

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement